Abstract

Mucosal inflammatory diseases, including inflammatory bowel disease (IBD), celiac disease, and allergic rhinitis, present significant clinical challenges due to their chronic nature and impact on patient quality of life. Central to these conditions are complex inflammatory cascades that involve various immune cells, cytokines, and signaling pathways. This review aims to elucidate the mechanisms underlying mucosal inflammation and identify potential therapeutic targets. Advances in our understanding of mucosal immunology have revealed novel insights into the initiation and perpetuation of inflammation, paving the way for innovative treatment strategies.